2 weeks Ago By ABMN Staff
Federated Hermes Inc. increased its position in shares of Solventum Co. ( NYSE:SOLV – Free Report ) by 231.
3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,359 shares of the company’s stock after acquiring an additional 1,647 shares during the period. Federated Hermes Inc.
’s holdings in Solventum were worth $156,000 at the end of the most recent reporting period. Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Edgewood Management LLC grew its holdings in Solventum by 1.
0% during the 4th quarter. Edgewood Management LLC now owns 75,062 shares of the company’s stock worth $4,959,000 after acquiring an additional 763 shares during the period. Russell Investments Group Ltd.
raised its stake in shares of Solventum by 29.5% in the fourth quarter. Russell Investments Group Ltd.
now owns 53,491 shares of the company’s stock worth $3,534,000 after purchasing an additional 12,174 shares during the last quarter. Envestnet Asset Management Inc. raised its position in Solventum by 0.
9% in the 4th quarter. Envestnet Asset Management Inc. now owns 180,629 shares of the company’s stock valued at $11,932,000 after buying an additional 1,665 shares during the last quarter.
Resona Asset Management Co. Ltd. purchased a new stake in shares of Solventum in the fourth quarter valued at about $3,029,000.
Finally, Integrated Quantitative Investments LLC purchased a new stake in Solventum in the 4th quarter valued at about $377,000. Solventum Stock Up 0.8 % SOLV stock opened at $66.
23 on Friday. The company has a market capitalization of $11.46 billion and a price-to-earnings ratio of 24.
08. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.
83 and a current ratio of 1.15. The business’s 50 day moving average price is $73.
41 and its two-hundred day moving average price is $71.61. Solventum Co.
has a fifty-two week low of $47.16 and a fifty-two week high of $85.92.
Analysts Set New Price Targets Get Our Latest Research Report on SOLV Solventum Company Profile ( Free Report ) Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. Featured Stories Want to see what other hedge funds are holding SOLV? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Solventum Co. ( NYSE:SOLV – Free Report ). Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.
com's FREE daily email newsletter ..
